GABA spectra and remote distractor effect in progressive supranuclear palsy: A pilot study

C Bonnet1, J Rusz2, J Hanuška3

  • 1Department of Neurology, Center of Clinical Neuroscience, Charles University, First Faculty of Medicine, General University Hospital, Kateřinská 30, Prague 2, 12000 Prague, Czech Republic; Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, 75013 Paris, France.

Revue Neurologique
|April 8, 2017
PubMed
Summary

This study investigated gamma-aminobutyric-acid (GABA) levels and eye-movement decisions in progressive supranuclear palsy (PSP). Researchers found no significant differences in GABA levels or decision-making abilities between PSP patients and healthy controls.

Related Concept Videos